To our surprise, anti-PD-1 treatment, besides inducing markers of anti-tumor immunity such as an increase in CD8+ T cells and IL-12 expression within the tumor, did not alter tumor development in the PyMT model. The gene discussed is PDCD1; the disease is neoplasm.